Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | -0.003 | 0.9 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
mRNA | HC-067047 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.9 |
mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.0042 | 0.9 |